{"disease":{"id":"safety-and-tolerability","name":"safety and tolerability"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01226316","title":"Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":285,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03702231","title":"Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT05469854","title":"A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"Cinclus Pharma AG","has_results":false},{"nct_id":"NCT07518589","title":"Phase 1 Study of Ascending Doses of CMS-D008 in Healthy and Overweight/Obese Adults","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Shenzhen Kangzhe Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06079541","title":"Phase 1 Clinical Study of JMKX003142 Tablets","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":106,"lead_sponsor_name":"Jemincare","has_results":false},{"nct_id":"NCT04783545","title":"Phase I Study of VLX-1005 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Veralox Therapeutics","has_results":false},{"nct_id":"NCT03672604","title":"A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Neuraly, Inc.","has_results":false},{"nct_id":"NCT06000891","title":"A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":84,"lead_sponsor_name":"Zealand Pharma","has_results":false},{"nct_id":"NCT03809052","title":"A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Galecto Biotech AB","has_results":true},{"nct_id":"NCT03685708","title":"HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":true},{"nct_id":"NCT04034784","title":"Discrete(TM) Safety Clinical Trial GLAD-01","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"ARC Medical Inc.","has_results":false},{"nct_id":"NCT07098663","title":"Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":68,"lead_sponsor_name":"Mankind Pharma Limited","has_results":false},{"nct_id":"NCT05431634","title":"Multiple Dose Study to Determine Safety and Tolerability of ESK-001 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Alumis Inc","has_results":false},{"nct_id":"NCT06453824","title":"SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"MDI Therapeutics, Inc.","has_results":false},{"nct_id":"NCT04535752","title":"A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Annexon, Inc.","has_results":false},{"nct_id":"NCT06894875","title":"Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Nuritas Ltd","has_results":false},{"nct_id":"NCT03046589","title":"DP13 SAD & MAD in Healthy Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Damian Pharma AG","has_results":false},{"nct_id":"NCT07226362","title":"A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Aspeya Switzerland SA","has_results":false},{"nct_id":"NCT06715163","title":"Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"AB Biotek","has_results":false},{"nct_id":"NCT03307512","title":"PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Dance Biopharm Inc.","has_results":false},{"nct_id":"NCT05451667","title":"Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Yuejia Pharmaceuticals (USA), Inc.","has_results":false},{"nct_id":"NCT03817346","title":"Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Gabather AB","has_results":false},{"nct_id":"NCT03239379","title":"A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Bioniz Therapeutics","has_results":false},{"nct_id":"NCT05223660","title":"A Phase I Pharmacokinetics Study for KT07 Capsule","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Yiling Pharmaceutical Inc.","has_results":false},{"nct_id":"NCT06181760","title":"A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Island Pharmaceuticals","has_results":true},{"nct_id":"NCT03853421","title":"Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Modus Therapeutics AB","has_results":false},{"nct_id":"NCT06331884","title":"Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"4TEEN4 Pharmaceuticals GmbH","has_results":true},{"nct_id":"NCT07346690","title":"A Study Testing the Effects of Different THC Doses on Psychological and Biological Function","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04085224","title":"6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT07153900","title":"BACK4 Safety Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"SWIMS America Corp.","has_results":false},{"nct_id":"NCT07300202","title":"CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Oriplantee Company Limited","has_results":false},{"nct_id":"NCT07308041","title":"A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Cinclus Pharma Holding AB","has_results":false},{"nct_id":"NCT06022744","title":"An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT06699758","title":"A Phase I, Single-Center, Open-Label, Dose-Escalation Clinical Trial to Assess the Safety and Tolerability of an Intranasal Memory T Lymphocytes Solution in Adult Females: vRELEASE I. (vRELEASE I)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Cristina Calvo Rey","has_results":false}],"total":34},"guidelines":[],"source":"Drug Landscape verified database"}